Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $118.9000 (-1.09%) ($117.0800 - $120.9300) on Thu. Nov. 2, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.12% (three month average) | RSI | 47 | Latest Price | $118.9000(-1.09%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR declines -0.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) IBB(44%) XLV(44%) XBI(42%) VYM(40%) VT(39%) | Factors Impacting UTHR price | UTHR will decline at least -1.06% in a week (0% probabilities). VIXM(-15%) TLT(-13%) UUP(-9%) TIP(-1%) SHY(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.06% (StdDev 2.12%) | Hourly BBV | 0 () | Intraday Trend | -1.4% | | | |
|
Resistance Level | $120.44 | 5 Day Moving Average | $119.52(-0.52%) | 10 Day Moving Average | $120.03(-0.94%) | 20 Day Moving Average | $120.44(-1.28%) | To recent high | -13.1% | To recent low | 3.8% | Market Cap | $5.274b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |